Cognitive enhancement : a brief overview

Outhoff, Kim

dc.contributor.author	Outhoff, Kim
dc.date.accessioned	2016-05-30T05:35:56Z
dc.date.available	2016-05-30T05:35:56Z
dc.date.issued	2016
dc.description.abstract	Cognitive enhancement involves the non-medical use of illicit and/or prescription drugs, such as agents prescribed for attention deficit/hyperactive disorder (ADHD) and narcolepsy, usually in order to stay awake and to counteract fatigue and loss of concentration, generally in the context of high workload and stress. Growing interest in taking prescription stimulant drugs for non-licensed purposes to improve academic, work and sporting performance has raised medical, ethical and regulatory issues.	en_ZA
dc.description.department	Pharmacology	en_ZA
dc.description.librarian	am2016	en_ZA
dc.description.uri	http://www.safpj.co.za/index.php/safpj	en_ZA
dc.description.uri	http://www.tandfonline.com/oemd	en_ZA
dc.identifier.citation	Outhoff, K 2016, 'Cognitive enhancement : a brief overview', South African Family Practice, vol. 58, no. 1, pp. 16-18.	en_ZA
dc.identifier.issn	2078-6190 (print)
dc.identifier.issn	2078-6204 (online)
dc.identifier.uri	http://hdl.handle.net/2263/52779
dc.language.iso	en	en_ZA
dc.publisher	MedPharm Publications	en_ZA
dc.rights	© 2016 The Author(s). Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0].	en_ZA
dc.subject	Cognitive enhancement	en_ZA
dc.subject	High workload	en_ZA
dc.subject	Narcolepsy	en_ZA
dc.subject	Stress	en_ZA
dc.subject	Attention deficit hyperactivity disorder (ADHD)	en_ZA
dc.title	Cognitive enhancement : a brief overview	en_ZA
dc.type	Article	en_ZA